Arvaya HealthcareBOM:524723 +4.99%34 Quick Ratio is 1.11 as of Mar. 2026, which is 98% below its 10-year median of 45.41. GuruFocus rates BOM:524723 with a GF Score™ of 34/100 and a GF Value™ of ₹49.23 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 118 Medical Distribution companies, Arvaya Healthcare ranks better than 55.08% on this metric.
Arvaya Healthcare has a quick ratio of 1.11. It generally indicates good short-term financial strength.
The historical rank and industry rank for Arvaya Healthcare's Quick Ratio or its related term are showing as below:
BOM:524723'
s Quick Ratio Range Over the Past 10 Years
Min: 1.11 Med: 45.41 Max: 88.66
Current: 1.11
During the past 13 years, Arvaya Healthcare's highest Quick Ratio was 88.66. The lowest was 1.11. And the median was 45.41.
BOM:524723's Quick Ratio is ranked better than 55.08% of 118
companies
in the Medical Distribution industry
Industry Median: 1.05
vs BOM:524723: 1.11
Arvaya Healthcare (BOM:524723) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Arvaya Healthcare Quick Ratio Related Terms
Arvaya Healthcare Quick Ratio Historical Data
* Premium members only.
The historical data trend for Arvaya Healthcare's Quick Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:524723 vs MCK, CAH, COR: Quick Ratio Comparison
For the Medical Distribution subindustry, Arvaya Healthcare's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Arvaya Healthcare Quick Ratio vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Arvaya Healthcare's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Arvaya Healthcare's Quick Ratio falls into.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
Arvaya Healthcare's Quick Ratio for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Arvaya Healthcare (BOM:524723) has a Quick Ratio of 1.11 as of Mar. 2026. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Arvaya Healthcare and its competitors. This is 98% below median its historical median of 45.41. Over the past decade, Arvaya Healthcare's Quick Ratio has ranged from 1.11 to 88.66. According to the industry distribution chart, Arvaya Healthcare ranks #53 out of 118 companies in the Medical Distribution industry, placing it in the top 44.9%.
Is Arvaya Healthcare's Quick Ratio too high?
Arvaya Healthcare's current Quick Ratio of 1.11 is 98% below median its 10-year median of 45.41. Over the past 10 years, this metric has ranged from a low of 1.11 to a high of 88.66. The Medical Distribution industry median Quick Ratio is 1.05. Arvaya Healthcare's value of 1.11 is 5.7% above this industry median. Based on the distribution chart, Arvaya Healthcare ranks #53 out of 118 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Arvaya Healthcare has a GF Score™ of 34/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Arvaya Healthcare's Quick Ratio compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Arvaya Healthcare ranks #53 out of 118 companies for Quick Ratio. This puts Arvaya Healthcare in the upper half of its industry. The industry median Quick Ratio is 1.05. Arvaya Healthcare's value of 1.11 is 5.7% above this benchmark. Historically, Arvaya Healthcare's own Quick Ratio has ranged from 1.11 to 88.66 over the past decade. While the company's 10-year median is 45.41 vs. the industry median of 1.05, Arvaya Healthcare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Medical Distribution company?
The median Quick Ratio among Medical Distribution companies is 1.05, based on 118 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Arvaya Healthcare's current Quick Ratio of 1.11 is 5.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Arvaya Healthcare and its competitors. For the Medical Distribution industry, the median Quick Ratio is 1.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Arvaya Healthcare's current Quick Ratio is 1.11, which is 98% below median its own 10-year median of 45.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Arvaya Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Arvaya Healthcare (BOM:524723) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹49.23, compared to a current price of ₹85.62 — trading 73.9% above its estimated fair value. The current Quick Ratio is 1.11, which is 98% below median its 10-year median of 45.41 and 5.7% above the Medical Distribution industry median of 1.05. Arvaya Healthcare's overall GF Score™ is 34/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Arvaya Healthcare (BOM:524723), the current Quick Ratio is 1.11 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Arvaya Healthcare (BOM:524723) Overvalued in 2026?
Based on GuruFocus' analysis, Arvaya Healthcare stock appears to be overvalued.
The current stock price of ₹85.62 is trading 73.9% above its estimated GF Value™ of ₹49.23.
GuruFocus considers Arvaya Healthcare to be Significantly Overvalued.
Key valuation signals for BOM:524723:
Quick Ratio: 1.11 (98% below median its 10-year median of 45.41)
GF Value™: ₹49.23 vs. price of ₹85.62 (73.9% above fair value)
Industry Position: 5.7% above the Medical Distribution median (#53 of 118)
No single metric tells the full story. See the BOM:524723 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Arvaya Healthcare Ltd is focused on developing an integrated healthcare platform in India that combines hospital services, diagnostics, wellness services, and digital health management solutions. Its operations include multi-specialty hospitals, a digital health platform for appointment booking and health record management, diagnostic services including laboratory testing and home sample collection, and wellness facilities offering preventive and recovery-focused programs.
34GF Score
Get the complete analysis for BOM:524723
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:524723 has been successfully added to your 
